Table 3. Comparison characteristics of hematologic cancer cases and individuals without a diagnosed hematologic cancer during study follow-up.
| Phenotype | N | Age at Study enrollment mean(sd) | Years to diagnosis Median | Years of study follow-up Median | Mosaic n (%) | Non-Mosaic n (%) |
| Leukemia | 51 | 71.2 (6.4) | 4.9 | 8 | 9 (17.6) | 42 (82.4) |
| NHL | 120 | 70.83 (6.3) | 5.5 | 10 | 5 (4.2) | 115 (95.8) |
| HL | 6 | 68.4 (3.0) | 7.48 | 9 | 0 (0) | 6 (100) |
| MDS | 6 | 76.1 (6.7) | 5 | 7.3 | 1 (16.7) | 5 (83.3) |
| MM | 46 | 70.8 (6.6) | 4.9 | 8.1 | 1 (2.2) | 45 (98.8) |
| No Hematologic Cancer | 11947 | 68.5 (7.58) | NA | 11.9 | 153 (1.3) | 11794 (98.7) |